Skip to content

Home
About Us
Office
E-Library
Research Support
Blog
Donation
Contact Us

Home
About Us
Office
E-Library
Research Support
Blog
Donation
Contact Us

Uncategorized

New Releases from NCBI BookshelfIsatuximab with pomalidomide and dexamethasone for treating relapsed and refractory multiple myeloma.Isatuximab with pomalidomide and dexamethasone for treating relapsed and refractory multiple myeloma.

Leave a Comment / Uncategorized / admin

Post Content

New Releases from NCBI BookshelfPembrolizumab for untreated metastatic or unresectable recurrent head and neck squamous cell carcinoma.Pembrolizumab for untreated metastatic or unresectable recurrent head and neck squamous cell carcinoma.

Leave a Comment / Uncategorized / admin

Post Content

New Releases from NCBI BookshelfPembrolizumab for untreated metastatic or unresectable recurrent head and neck squamous cell carcinoma.Pembrolizumab for untreated metastatic or unresectable recurrent head and neck squamous cell carcinoma.

Leave a Comment / Uncategorized / admin

Post Content

New Releases from NCBI BookshelfCaplacizumab with plasma exchange and immunosuppression for treating acute acquired thrombotic thrombocytopenic purpura.Caplacizumab with plasma exchange and immunosuppression for treating acute acquired thrombotic thrombocytopenic purpura.

Leave a Comment / Uncategorized / admin

Post Content

New Releases from NCBI BookshelfEmergency Medical Services Streaming Enabled Evaluation In Trauma: The SEE-IT Feasibility RCT [Internet].Emergency Medical Services Streaming Enabled Evaluation In Trauma: The SEE-IT Feasibility RCT [Internet].

Leave a Comment / Uncategorized / admin

Some text in this abstract and article has been reproduced from Taylor et al. (Taylor C, Ollis L, Lyon RM,

New Releases from NCBI BookshelfOsimertinib for treating EGFR T790M mutation-positive advanced non-small-cell lung cancer.Osimertinib for treating EGFR T790M mutation-positive advanced non-small-cell lung cancer.

Leave a Comment / Uncategorized / admin

Post Content

New Releases from NCBI BookshelfGlasdegib with chemotherapy for untreated acute myeloid leukaemia (terminated appraisal).Glasdegib with chemotherapy for untreated acute myeloid leukaemia (terminated appraisal).

Leave a Comment / Uncategorized / admin

Post Content

New Releases from NCBI BookshelfSputum colour charts to guide antibiotic self-treatment of acute exacerbation of chronic obstructive pulmonary disease: the Colour-COPD RCT [Internet].Sputum colour charts to guide antibiotic self-treatment of acute exacerbation of chronic obstructive pulmonary disease: the Colour-COPD RCT [Internet].

Leave a Comment / Uncategorized / admin

Chronic obstructive pulmonary disease exacerbations (acute exacerbation of chronic obstructive pulmonary disease) are characterised by increased sputum volume, purulence and

New Releases from NCBI BookshelfNivolumab for advanced squamous non-small-cell lung cancer after chemotherapy.Nivolumab for advanced squamous non-small-cell lung cancer after chemotherapy.

Leave a Comment / Uncategorized / admin

Post Content

New Releases from NCBI BookshelfEculizumab for treating relapsing neuromyelitis optica (terminated appraisal).Eculizumab for treating relapsing neuromyelitis optica (terminated appraisal).

Leave a Comment / Uncategorized / admin

Post Content

← Previous 1 … 53 54 55 … 217 Next →

Useful Links

NEWREDMARS SKILL AND RESEARCH FOUNDATION

Registration No: 771800548 Contact Number : +91-8249516996

Publication
Skill Development
Blog Writing

Research
Awareness Camp
Digital Research

Ngo Darpan
Service
Donation

©2021-2024. Newredmars Skill and Research Foundation. All Rights Reserved.

Term and Condition
Privacy Policy
Disclaimer

Scroll to Top